When it comes to the Analysis of a Stock, Price Target plays a vital role. Sell-side analyst recommendations point to a short term price target of $65.38 on the shares of Alnylam Pharmaceuticals, Inc. Keryx …
Keryx Biopharmaceuticals
Turning to Return on Assets or ROA, Keryx Biopharmaceuticals Inc (KERX) has a current ROA of -80.52. As for the doubters, 5 equity research analyst firms call this stock a "Hold" and 0 consider it bad enough to warrant a …
Keryx Biopharmaceuticals Inc
Investors eyeing a purchase of Keryx Biopharmaceuticals Inc. (KERX) stock, but cautious about paying the going market price of $5.82/share, might benefit from considering selling puts among the alternative strategies at …
Purchase Keryx Biopharmaceuticals
The stock price of KERX is moving up from its 20 days moving average with 8.45% and isolated positively from 50 days moving average with 5.60%. The Stock now has the market capitalization of $611.57 Million, P/E (price …
Keryx Biopharmaceuticals Inc
We issued an updated research report on Keryx Biopharmaceuticals, Inc.KERX on Mar 15, 2017 ... Keryx is a Zacks Rank #3 (Hold) stock. You can see the complete list of today's Zacks #1 (Strong Buy) Rank stocks …
Keryx
The current share price indicate that stock is -24.94% away from its one year high and is moving 31.72% ahead of its 52-week low. Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) announced that the nation’s largest …
TASER International
ticker=KERX Omerus spiked up $1.54 from Friday's close to end Monday ... and disorders of the central nervous system. The stock is up almost 18.5 percent for the year-to-date, and its lead candidate therapy, OMS721, is …
Keryx Biopharmaceuticals
Keryx Biopharmaceuticals was off to an incredibly strong start to the trading session today. However, the shares have been halted and news is pending. Today, we'll talk about what we've seen from the stock thus far today, …
Prescription Drug User Fee Act
Investors in Keryx Biopharmaceuticals Inc. (NASD: KERX) saw new options become available this week, for the August 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the KERX